Jump to search

July 2016arrow

Hybrid treatment hunts down and kills leukemia cells

July 28, 2016

Researchers at UC Davis and Ionis Pharmaceuticals have developed a hybrid treatment that harnesses a monoclonal antibody to deliver antisense DNA to acute lymphoblastic leukemia (ALL) cells and that may lead to less toxic treatments for the disease.

2016-2017 MIND Institute Distinguished Lecturer Series starts Sept. 14

July 27, 2016

The UC Davis MIND Institute kicks off its 2016-2017 Distinguished Lecturer Series in September with an address by Robert H. Ring, associate professor at Drexel University in the College of Medicine, Department of Pharmacology and Physiology.

De Vere White to serve on prestigious NIH panel

July 26, 2016

Ralph de Vere White, who retired in June as director of the UC Davis Comprehensive Cancer Center, has been named to a key committee at the National Institute of Health (NIH).

UC Davis scientists awarded grant for rare genetic disorder research

July 21, 2016

The state stem cell agency, the California Institute for Regenerative Medicine (CIRM), today approved a $1.1 million grant to UC Davis for research aimed at developing a treatment for Angelman syndrome,  a rare, neurogenetic autism-spectrum disorder that occurs in one in 15,000 live births.

UC Davis researchers temporarily turn off brain area to better understand function

July 20, 2016

Capitalizing on experimental genetic techniques, researchers at UC Davis’ California National Primate Research Center (CNPRC) have demonstrated that temporarily turning off an area of the brain changes patterns of activity across much of the remaining brain.

High quality MRIs without sedation are possible in severely affected children with autism

July 19, 2016

UC Davis researchers have found a way to get MRI images of children with autism spectrum disorder (ASD) and intellectual disability without sedating them first using the principles of applied behavior analysis.

Historic data to aid in long-term study of ethnic disparities in brain health and dementia

July 14, 2016

Physical exams conducted from the 1960s through the 1980s will be revisited to evaluate risks and protective factors in early and midlife that could affect brain health and dementia diagnoses among a large, ethnically diverse group of seniors. The Kaiser Permanente Northern California Division of Research will partner with the UC Davis Alzheimer’s Disease Center for the study, which is funded with a five-year, $13 million grant from the National Institute on Aging.

Oncologists and cancer patients often differ in prognosis perceptions

July 14, 2016

Patients with stage III or IV cancer report far more optimistic expectations for survival than their oncologists thought they had communicated, according to new research published today in JAMA Oncology. Effective communication between doctors and their patients who could be nearing the end of their lives is crucial, according to the authors, since this is when quality-of-life decisions merge with discussions about treatment options.

New grant further solidifies UC Davis' leadership role in translational research

July 12, 2016

The UC Davis Clinical and Translational Science Center (CTSC) and the wide array of services that have supported innovative biomedical research and led to the development of new treatments for diseases during the past 10 years will continue, thanks to a $27.8 million grant from the National Center for Accelerating Translational Science and the ongoing support from the School of Medicine.

UC Davis scientists awarded grant for rare genetic disorder research

July 5, 2016

The London-based LouLou Foundation, in partnership with the Orphan Disease Center of the Perelman School of Medicine at the University of Pennsylvania, has awarded a grant to UC Davis Institute for Regenerative Cures Director Jan Nolta and one of the institute’s post-doctoral fellows, Kyle Fink, to study how Fink’s gene editing techniques might be used to treat a rare genetic disorder that hits children – mainly girls – at a very young age with difficult-to-control seizures and severe neuro-developmental impairment.

June 2016arrow

Beware of unapproved stem cell procedures

June 30, 2016

At least 351 companies across the United States are marketing unapproved stem cell procedures, according to a new study by a UC Davis stem cell researcher and a University of Minnesota bioethicist.

Study shows that some, but not all, premenstrual symptoms are linked with inflammation

June 23, 2016

Certain premenstrual symptoms, such as mood changes, breast pain and abdominal cramps, are linked with inflammation, but headache is not, according to new research from UC Davis Health System. Published in the current issue of the Journal of Women’s Health, the results suggest that anti-inflammatory medications may be appropriate for some but not all symptoms associated with menstruation.

"Digital neurotherapeutic" in development at the UC Davis MIND Institute

June 22, 2016

A UC Davis researcher has created a video game for children who experience cognitive impairments from genetic disorders with the hope that that it will improve their ability to mentally process information about space and time.

Nearly 10 million U.S. adults severely nearsighted

June 22, 2016

A new study by investigators at the American Academy of Ophthalmology, Genentech, the National Institutes of Health and UC Davis Eye Center has found that 9.6 million U.S. adults are highly myopic, or severely nearsighted, and of those, nearly 820,000 have a degenerative form of the disease and more than 41,000 suffer myopic choroidal neovascularization, a complication that can cause long-term vision loss, especially in women.

MIND Institute researcher studies feasibility of community providers training parents of children with autism

June 22, 2016

Research has long shown that parent-implemented “naturalistic developmental behavioral interventions,” which are applied in a child’s usual setting and designed to build developmentally appropriate skills, help decrease the main symptoms of autism spectrum disorder (ASD). However, parent training by community providers had not previously been studied.

Mothers with diabetes, other metabolic conditions, more likely to also have anti-fetal brain autoantibodies

June 17, 2016

Mothers of children with autism who were diagnosed with metabolic conditions during pregnancy, particularly gestational and type 2 diabetes, were more likely to have anti-fetal brain autoantibodies in their blood compared to healthy women of children with autism. The presence of these anti-fetal brain autoantibodies has been previously found to be specific to some mothers of children with autism and rare among mothers of children without autism, researchers with the UC Davis MIND Institute have found.

UC Davis study finds antibiotics increase availability of nutrients in the gut, enabling growth of pathogens

June 15, 2016

Research led by Andreas Bäumler, professor of medical immunology and microbiology at UC Davis Health System, has identified a new mechanism explaining how antibiotics change the gut microbiota, increasing nutrients that benefit the growth of pathogens, like Salmonella.

UC Davis establishes research center to tackle pain epidemic

June 13, 2016

Leveraging the vast expertise of scholars and scientists in medicine, nursing and other health science disciplines, UC Davis has established the Center for Advancing Pain Relief.

NIH funding for dermatology research trending downward for women and MDs

June 9, 2016

In a retrospective study of dermatology research awards from the National Institutes of Health (NIH) from 2009 to 2014, a team of UC Davis researchers found a significant decline in women investigators and a striking reduction in MD-only investigator funding dollars.

Risk of autism with intellectual disability linked with maternal immune dysfunction during pregnancy

June 7, 2016

Pregnant women with higher levels of inflammatory cytokines and chemokines, proteins that control communication between cells of the immune system, may be at significantly greater risk of having a child with autism combined with intellectual disability, researchers with the UC Davis MIND Institute have found.

Lung cancer patients who have surgery live longer

June 7, 2016

Patients with late-stage, non-small cell lung cancer (NSCLC) who have surgery have better survival rates than those who don’t, but fewer of these patients are undergoing surgery, UC Davis researchers have found.

May 2016arrow

MIND Institute study examines development of school-age children with autism spectrum disorder

May 27, 2016

Grade school is an important period in children’s development, when they begin to mature and prepare to enter adolescence. Now, researchers with the UC Davis MIND Institute hope to discover how to maximize that growth among children with autism to help them learn and thrive.

Inhaled silver particles end up in the brain, UC Davis study shows

May 26, 2016

Airborne silver nanoparticles that are common in occupational settings travel from the nose to the brain, where they can remain for weeks and trigger an immune response linked with injury, UC Davis researchers studying adult rats have found.

Miglioretti awarded $7.5 million to evaluate supplemental breast imaging

May 25, 2016

Diana Miglioretti, UC Davis dean’s professor of biostatistics and an internationally recognized breast cancer screening expert, has received $7.5 million to determine the effectiveness of two supplemental breast screening and diagnostic workup strategies -- digital breast tomosynthesis (3D mammography) and magnetic resonance imaging (MRI) -- used with mammography for cancer detection. Miglioretti’s team also will work to determine whether effectiveness of the screening strategies depends on a woman’s breast density.

UC Davis Alzheimer's Disease Center establishes new Cognitive Neurosciences Fellowship

May 25, 2016

The UC Davis Alzheimer’s Disease Center has established a new, integrated translational cognitive neuroscience postdoctoral fellowship program through a five-year, $1 million grant from the National Institute on Aging.

Calcium channels team up to activate excitable cells

May 18, 2016

Voltage-gated calcium channels open in unison, rather than independently, to allow calcium ions into and activate excitable cells such as neurons and muscle cells, researchers with UC Davis Health System and the University of Washington have found.

Physicians can counsel patients to prevent gun violence, experts say

May 17, 2016

It is not illegal for physicians to ask their patients about firearms, counsel them as they would on any other health matter, and disclose that information to third parties when necessary, according to a review of the literature by physicians at UC Davis, Brown University, and the University of Colorado who are helping to lead the effort to prevent firearm-related injuries in the U.S.

UC Davis researchers identify new metabolic disorder

May 12, 2016

Researchers at UC Davis have identified a new metabolic disorder that affects newborns and leads to death hours after their birth. Identification of the genetic defect has meant the delivery of a healthy newborn to a mother who earlier had lost two other newborns to the condition.

More research needed to identify and measure quality of autism interventions

May 10, 2016

With the dramatic rise of children diagnosed with autism spectrum disorder (ASD), the numbers and types of interventions promoted to families and individuals with autism have surged as well.

Device worn on eyeglasses offers hope for people with low vision

May 5, 2016

A miniature camera using optical character-recognition technology, mounted onto the eyeglasses of people who are considered legally blind, dramatically improves their ability to read an email, newspaper article, menu or page in a book, a study by researchers with UC Davis Health System.

UC Davis teams receive prestigious CITRIS awards for innovation in human health

May 4, 2016

Three UC Davis Health System teams have been selected from among 54 highly competitive proposals to receive awards to develop innovative information technology solutions in human health care from the Center for Information Technology Research in the Interest of Society — CITRIS — a collaboration of the UC campuses at Berkeley, Davis, Merced and Santa Cruz. The grants are awarded in collaboration with the Banatao Institute founded by high-tech entrepreneur and philanthropist Dado Banatao.  

Autism and cancer share a remarkable number of risk genes in common

May 3, 2016

Autism and cancer share more than 40 risk genes, suggesting that common mechanisms underlying the functions of some of these genes could conceivably be leveraged to develop therapies not just for cancer but for autism as well, an extensive assessment by researchers with the UC Davis MIND Institute and Comprehensive Cancer Center has found.

Antibiotics allow gut pathogens to breathe

May 2, 2016

Antibiotics are essential for fighting bacterial infection, but, paradoxically, they can also make the body more prone to infection and diarrhea. Research led by Andreas Bäumler, professor of medical immunology and microbiology at UC Davis Health System, has identified the chain of events that occur within the gut lumen after antibiotic treatment that allow “bad” bugs to flourish.

Common supplement boosts kidney cancer therapy

May 2, 2016

Researchers at UC Davis have shown that docosahexaenoic acid (DHA), a fatty acid commonly found in fish and fish oil supplements, reduces renal cell carcinoma invasiveness, growth rate, and blood vessel growth when combined with the anti-cancer therapy regorafenib. The study was published in the May issue of the journal Molecular Cancer Therapeutics.

Targeted hepatitis B virus screening effective in addressing infection, liver disease risk

May 2, 2016

A community-based hepatitis B virus screening effort led by UC Davis researchers found that targeted outreach to Asian American populations can identify groups at high risk for infection and direct them to appropriate follow-up care to help prevent the onset of liver diseases, including cancer.

April 2016arrow

Stem cell research reveals myelin repair capacity

April 28, 2016

In a study published today in Cell Reports, Wenbin Deng and his colleagues present data showing that immature astroglial transplants, derived from human-induced pluripotent stem cells (iPSCs), are highly protective against white matter brain injury — which can occur from lack of oxygen following a stroke or in childbirth — and can improve spatial learning and memory function in mouse models.

Distance language intervention helps adolescents with disabilities communicate

April 27, 2016

Sean Sawicki, who has fragile X syndrome, can be hard to understand and doesn’t always have the attention span to carry on a sustained conversation. But a novel intervention developed by UC Davis MIND Institute researchers seems to be making a difference.

SU2C awards Albeck Innovative Research Grant

April 26, 2016

UC Davis molecular biologist John Albeck is among 10 recipients chosen to receive a 2016 Innovative Research Grant (IRG) from Stand Up to Cancer (SU2C), a non-profit that supports innovative, high-risk, high-reward projects to accelerate the pace of cancer research and give patients access to new therapies as quickly as possible.

Weighing the pros and cons of mental-health apps

April 26, 2016

“There’s an app for that.” The phrase is so ubiquitous it’s a meme, and trademarked by Apple Inc.

New study tests stem cells as a treatment for degenerative disc disease

April 25, 2016

As part of a new multicenter clinical trial, UC Davis Health System researchers will test whether a novel stem cell treatment can reduce the pain and mobility issues caused by degenerative disc disease.

UC Davis MIND Institute joins SPARK, nation's largest autism research study

April 21, 2016

The UC Davis MIND Institute in Sacramento, Calif. today helped launch SPARK, an online research initiative designed to become the largest autism study ever undertaken in the United States. Sponsored by the Simons Foundation Autism Research Initiative (SFARI), SPARK will collect information and DNA for genetic analysis from 50,000 individuals with autism — and their families — to advance our understanding of the causes of this condition and to hasten the discovery of supports and treatments. [español]

International Cancer Genome Consortium for Medicine launch announced

April 17, 2016

The International Cancer Genome Consortium (ICGC) today announced plans to launch of the International Cancer Genome Consortium for Medicine (ICGCmed), a new phase in the consortium’s evolution that will link genomics to clinical information and health.

Use of clot-blocking device should be rare, UC Davis study finds

April 13, 2016

Devices intended to stop potentially deadly blood clots from reaching the lungs can help a small portion of the patients who receive them but can also increase the risk of additional clots, researchers at UC Davis Health System have found.

Radiation improves survival in older patients with soft tissue sarcomas

April 11, 2016

UC Davis researchers have shown that radiation therapy following surgery benefits older patients more than their younger counterparts, a surprising finding that could change the way some patients are treated for soft tissue sarcomas (STS).

Behavioral Health Center of Excellence holds seminar on Firearm Violence and Mental Illness

April 7, 2016

Each year in the United States, firearm violence results in approximately 30,000 deaths and 75,000 nonfatal injuries to patients seen in hospital emergency rooms. Garen Wintemute, internationally renowned director of the Violence Prevention Research Program at UC Davis Health System, will discuss “Firearm Violence and Mental Illness.”

Whites receive more state funding for autism services than other racial/ethnic groups

April 4, 2016

Whites with autism spectrum disorder (ASD) in California receive more state funding than Hispanics, African Americans, Asians and others, new research from UC Davis Health System has found. The study also showed that spending on ASD increases dramatically with age. [en español]

March 2016arrow

Cancer gene twice as likely to be defective in children with autism

March 30, 2016

A large study by researchers with the UC Davis MIND Institute has found that a gene whose role is to suppress cellular damage from environmental stressors is nearly twice as likely to be defective in children with autism spectrum disorder (ASD), and that the deficit is also present in their fathers.

Vascular brain injury is evident in people in their 40s

March 28, 2016

A large, multicenter study led by the UC Davis School of Medicine for the first time has shown that people as young as their 40s have stiffening of the arteries that is associated with subtle structural damage to the brain that is implicated in cognitive decline and Alzheimer’s disease later in life.

New target makes end run against therapy-resistant prostate cancer

March 28, 2016

Researchers at UC Davis, in collaboration with the other institutions, have found that suppressing the nuclear receptor protein ROR-γ with small-molecule compounds can reduce androgen receptor (AR) levels in castration-resistant prostate cancer and stop tumor growth.

Hispanics with dementia receive antipsychotic medications at twice the rate of non-Hispanics

March 24, 2016

Antipsychotic medications are prescribed to Hispanics with Alzheimer’s disease or other dementias at higher rates than non-Hispanic whites, for dementia-related mental-health symptoms such as depression, anxiety and aggression, a UC Davis study conducted using data from a large and diverse population of elderly dementia patients has found.

Cells sensing hostile takeover by pathogens also sound alarm to alert immune system

March 23, 2016

Researchers at UC Davis have discovered an unexpected link between how the immune system sounds an alarm when its cells are taken over by pathogens during an infection and how an inflammatory response is triggered. The finding of this novel link, published in the journal Nature on March 23, is important because it helps researchers understand how a cell senses bacterial or viral infection, and how these pathways are linked to inflammatory diseases, such as inflammatory bowel disease, diabetes and atherosclerosis.

Heavy, persistent pot use linked to economic and social problems at midlife

March 23, 2016

A research study that followed children from birth up to age 38 has found that people who smoked cannabis four or more days of the week over many years ended up in a lower social class than their parents, with lower-paying, less skilled and less prestigious jobs than those who were not regular cannabis smokers. [en español]

Targeted interview technique could help doctors improve patient outcomes

March 21, 2016

New UC Davis Health System research shows that physicians can quickly and easily use a directed communication approach known as SEE IT (or Self-Efficacy Enhancing Interviewing Techniques) that is designed to boost patient confidence in managing chronic disease symptoms and increase the likelihood that they will make healthy changes that improve outcomes.

State stem cell agency approves research funding for UC Davis scientists

March 21, 2016

Two new UC Davis research efforts, one aimed at addressing fatal early childhood conditions known as Tay-Sachs and Sandhoff disease, the other designed to develop an immunotherapy that would eradicate solid tumor cancer stem cells and create sustained anti-tumor effects, have been approved for funding by the California Institute for Regenerative Medicine (CIRM).

School of Medicine again ranked among nation's best

March 16, 2016

Once again, U.S. News & World Report has ranked UC Davis School of Medicine among America's best medical schools for the quality of its educational programs in primary care and research.

Human stem cells target Huntington's disease

March 15, 2016

In a promising finding for research into Huntington’s disease (HD) — the devastating inherited neurodegenerative disorder — a team of UC Davis investigators has identified for the first time a way to use human mesenchymal stem cells (MSCs) to deliver the key brain protein growth factor that is dramatically diminished by Huntington’s disease.

UC Davis environmental health researcher receives grant for DDT study

March 4, 2016

UC Davis environmental scientist Michele La Merrill is among five exceptional early-career scientists receiving grants from the National Institute of Environmental Health Sciences (NIEHS) for research on how substances in the environment could harm human health.

February 2016arrow

How the brain handles teleportation

February 25, 2016

Technology may not have caught up to the teleportation devices of science fiction, but now we have some idea of how the brain handles “beaming up” from one location to another, thanks to research by neuroscientists at the University of California, Davis, involving some specially wired volunteers.

This is your brain on exercise

February 23, 2016

People who exercise have better mental fitness, and a new imaging study from UC Davis Health System shows why. Intense exercise increases levels of two common neurotransmitters — glutamate and gamma-aminobutyric acid, or GABA — that are responsible for chemical messaging within the brain.

UC Davis neuroscientist named Sloan fellow

February 23, 2016

Megan Y. Dennis, an early-career UC Davis scientist, has been named a 2016 Alfred P. Sloan Research Fellow in Neuroscience.

New study tests stem cells as a treatment for degenerative disc disease

February 10, 2016

As part of a new multicenter clinical trial, UC Davis Health System researchers will test whether a novel stem cell treatment can reduce the pain and mobility issues caused by degenerative disc disease.

Finding new targets to battle drug resistance

February 1, 2016

Researchers at UC Davis and Lawrence Livermore and Los Alamos national laboratories have created a chemotherapy-resistant line of bladder cancer cells to study how tumors become resistant to chemotherapy and identified molecular changes that could drive that resistance.

January 2016arrow

Young, poor African Americans and Hispanics have harder time beating Hodgkin Lymphoma

January 29, 2016

African American and Hispanic adolescents and young adults fare far worse than their white counterparts when faced with a mostly curable type of cancer, Hodgkin lymphoma, a study by a UC Davis epidemiologist has found.

Researchers decipher stem cell messages in blood vessel formation

January 19, 2016

An international collaboration between UC Davis and Swedish scientists has resulted in the first comprehensive characterization of a recently discovered cell-to-cell communication system used by stem cells.

Telemedicine in the ICU: It can be a cost-effective option

January 15, 2016

UC Davis investigators have found that telecommunication systems that provide remote monitoring and access to specialty care in intensive care units (ICUs) are cost-effective in most cases and can even be cost-saving in certain circumstances, making this intervention potentially economically favorable compared with other health-care services.

More research needed on evaluation of dense breasts

January 11, 2016

A systematic review of the scientific literature on dense breasts by researchers at UC Davis and other institutions has found that determinations of breast density can be unreliable and that as many as 19 percent of women are re-categorized as dense rather than non-dense or vice versa from one mammogram to the next.

Making a safe procedure even safer

January 11, 2016

In a comprehensive modeling study, researchers from UC Davis and other institutions have found that breast cancer screening with digital mammography poses only a small risk of radiation-induced breast cancer for most women.

December 2015arrow

A better way to treat deadly Aspergillus mold infection

December 17, 2015

Researchers at UC Davis and other institutions have shown that isavuconazole, a new treatment for invasive mold diseases such as Aspergillus, has fewer side effects than voriconazole and is just as effective. These results are good news for leukemia and lymphoma patients, who can be vulnerable to these opportunistic infections. The study was published Dec. 9 in The Lancet. 

Two UC Davis experts among speakers at World Stem Cell Summit

December 9, 2015

Two UC Davis Health System scientists are among the featured speakers at the upcoming World Stem Cell Summit and Regenerative Medicine conference that starts Dec. 10 in Atlanta.

A visit to the gas station: Protein helps power up DNA repair

December 3, 2015

In a game-changing study, researchers at UC Davis and other organizations have shown that the enzyme cyclin-dependent kinase 1 (CDK1), which plays a key role in DNA repair, also leaves the nucleus to boost cellular energy production. By irradiating normal cells, the team showed that CDK1 turned up production of ATP, cellular energy packets that – in this case – provided the necessary power supply to fix the radiation-damaged DNA.

Knuckle cracking looks explosive, but causes no detectable harm

December 1, 2015

UC Davis Health System research presented today at the annual meeting of the Radiological Society of North America in Chicago helps resolve two persistent questions about knuckle cracking: What causes the “crack” sound, and does it damage the hand?

November 2015arrow

UC Davis researchers find success in tele-audiology program

November 24, 2015

Researchers at UC Davis have shown that the California Tele-Audiology Program (CTP), which provides follow-up diagnostic evaluations for infants who did not pass their initial newborn hearing test, dramatically improves access to audiologists. [en español]

Common pigeon: Not just a bird brain, but a brainy bird

November 18, 2015

If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study from researchers at the University of California, Davis and The University of Iowa has found.

Lam receives $4 million in NIH grants for novel cancer research

November 18, 2015

Kit Lam, professor and chair of the Department of Biochemistry and Molecular Medicine, has been awarded two major, multi-disciplinary U01 grants from the National Institutes of Health (NIH), the first to investigate use of a new tool to visualize cancer tumor growth and response to nanoparticle drugs, and the other to develop a new 4-D imaging tool to advance the understanding of how the nucleus functions in living cells.

Small RNA has big impact on prostate cancer

November 17, 2015

Researchers at the UC Davis Comprehensive Cancer Center have shown that the microRNA, miR-124, reduced tumor growth and increased cell death in castration-resistant prostate cancer.

Statewide cancer report finds significant disparities in outcomes, quality of care by insurer

November 5, 2015

A new report by the UC Davis Institute for Population Health Improvement (IPHI) comparing quality of care and outcomes for breast, colon, rectal, lung and prostate cancers according to source of health insurance coverage has identified substantial disparities in stage of diagnosis, providers’ use of recommended treatment and survival rates.

New technology will help define the environmental triggers of childhood asthma

November 4, 2015

UC Davis researchers have received a four-year, $1.5 million grant from the National Institutes of Health to develop a small, wearable sensor that can measure the relationship between environmental exposures and pediatric asthma.

October 2015arrow

MIND Institute offers program for adults with autism spectrum disorder

October 29, 2015

Researchers with the Behavioral Health Center of Excellence and MIND Institute at UC Davis are seeking adult participants, aged 18 to 38 years and diagnosed with or suspected of having autism or Asperger’s disorder, to participate in a research study, the ACCESS Program (Acquiring Career, Coping, Executive-Function and Social Skills Program).

Menopausal status a better indicator than age for mammography frequency

October 20, 2015

In a study conducted to inform American Cancer Society breast cancer screening guidelines, UC Davis researcher Diana L. Miglioretti reports a screening mammogram once every two years is safe for postmenopausal women at average risk of breast cancer.

Bilingual website boosts awareness of kidney transplantation and donation among Hispanics/Latinos

October 7, 2015

A new bilingual website sensitive to Hispanic/Latino cultural needs increases knowledge about living kidney donation and transplantation beyond standard education provided by transplant centers, a new study published Oct. 7 in the journal Transplantation has found. [en español]

UC Davis granted $15.5 million to build world's first total-body PET scanner

October 6, 2015

A UC Davis research team has been awarded $15.5 million to build the world’s first total-body positron emission tomography (PET) scanner, which could fundamentally change the way cancers are tracked and treated and put the university on the nation’s leading edge of molecular imaging.

September 2015arrow

New treatments a big step for patients with advanced kidney cancer

September 29, 2015

In an editorial published in the New England Journal of Medicine, Primo Lara, associate director for Translational Research at the UC Davis Comprehensive Cancer Center and David Quinn, medical director, USC Norris Cancer Hospital, highlight two new drugs that have shown great efficacy against kidney cancer.

UC Davis researcher advocates ending Medicare coverage of controversial mammography tool

September 28, 2015

A costly tool used on nearly all mammograms does not increase cancer detection rates and should no longer be covered by Medicare, argues Joshua Fenton, a family physician and comparative effectiveness researcher in an editorial published online today in the Journal of the American Medical Association Internal Medicine.

UC Davis to test a computer program designed to reduce suicide

September 25, 2015

UC Davis Health System researchers have received a four-year, $1.3 million grant from the U.S. Centers for Disease Control and Prevention (CDC) to use a technology-based approach to help prevent suicide among those most at risk: middle-aged men.

Tumor suppressor LRIG1 controls breast cancer aggression and invasion

September 21, 2015

Researchers at UC Davis have shown that the protein LRIG1 reduces breast cancer invasion and could potentially help control metastasis. Using aggressive basal-like breast cancer cell lines, the scientists found that restoring LRIG1 expression reduced these cells’ growth and invasiveness.

UC Davis MIND Institute studies the use of sertaline (Zoloft ®) in young children with autism spectrum disorder

September 18, 2015

Whether the language and social development of very young children with ASD can be improved through treatment with sertraline, commonly known by the brand name Zoloft ®, is the subject of a new clinical trial at the UC Davis MIND Institute.

Cancer Center joins collaborative molecular oncology intiative

September 15, 2015

The UC Davis Comprehensive Cancer Center has joined a unique new collaboration to accelerate the development of precision cancer treatment through the collection and sharing of genomics data

Low vitamin D among the elderly is associated with significant decline in cognition, dementia

September 14, 2015

Vitamin D insufficiency among the elderly is highly correlated with accelerated cognitive decline and impaired performance, particularly in domains such as memory loss that are associated with Alzheimer’s disease and dementia, researchers with the UC Davis Alzheimer’s Disease Center and Rutgers University have found. [en español] [中文 Chinese]

UC Davis study shows popular molecular tests over diagnose C. difficile infections up to 50 percent

September 8, 2015

Clostridium difficile is a common cause of infection and diarrhea in hospitalized patients, but a new study by UC Davis pathologists suggests that many patients are mistakenly diagnosed and do not need antibiotic treatment.

August 2015arrow

UC Davis researchers receive $5.4 million grant to study new tool to evaluate early-stage Alzheimer's

August 31, 2015

Alzheimer’s researchers at UC Davis and UC San Diego have launched a new study which aims to detect the earliest stages of cognitive dysfunction in people with pre-clinical Alzheimer’s disease by using event-related brain potentials (ERPs).

New York Blood Center partners with UC Davis Health System to produce more viable stem cell therapies

August 20, 2015

New York Blood Center (NYBC) today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.

UC Davis team finds early inflammatory response paralyzes T cells

August 18, 2015

In a discovery that is likely to rewrite immunology text books, researchers at UC Davis have found that early exposure to inflammatory cytokines, such as interleukin 2, can “paralyze” CD4 T cells, immune components that help orchestrate the body’s response to pathogens and other invaders.

UC Davis to employ canines to sniff out cancer

August 17, 2015

UC Davis clinicians are hoping to greatly advance cancer screenings with the innate olfactory skills of man’s best friend.

A better way to personalize bladder cancer treatments

August 13, 2015

Researchers at UC Davis, in collaboration with colleagues at Jackson Laboratory, have developed a new way to personalize treatments for aggressive bladder cancer.

New UC Davis environmental research center links science with advocacy

August 12, 2015

A cross-disciplinary center focused on identifying connections between environmental toxins and disease has been established at UC Davis Health System with the ultimate goal of developing preventions and policies that protect communities from unhealthy exposures.

New combination treatment effective against melanoma skin metastases

August 11, 2015

mIn findings never before seen in melanoma, a novel combination therapy was found to be highly effective at treating patients with skin metastases, new research from UC Davis has shown.

Using kidneys from very small donors for transplant is safer than expected

August 10, 2015

Kidneys transplanted from infants who died of birth-related or other complications are less likely to fail due to a post-surgical vascular complication known as graft arterial stenosis (GAS) than kidneys from deceased adults, resesarchers have found.

UC Davis clinical research scientist wins second Hartwell Foundation award for pediatric cancer research

August 7, 2015

UC Davis pediatric oncologist and researcher Noriko Satake has been awarded a 2015 Hartwell Biomedical Research Collaboration Award from The Hartwell Foundation, a philanthropy that funds innovative and leading-edge biomedical research with the potential to benefit children of the United States. This is the first time a Hartwell investigator from UC Davis has received the Foundation’s inter-institutional Collaboration Award.

Cherry lands top NCI grant

August 6, 2015

Simon Cherry, distinguished professor in the departments of Biomedical Engineering and Radiology, and co-leader of the UC Davis Comprehensive Cancer Center’s Biomedical Technology Program, has been selected to receive a prestigious Outstanding Investigator Award from the National Cancer Institute (NCI).

Raising pay can reduce smoking rates

August 6, 2015

In addition to restricting when and where tobacco is used at work, UC Davis Health System research shows that employers can do something else to reduce the number of employees who smoke: raise wages.

Long-term ovarian cancer survival higher than thought

August 5, 2015

Combing data collected on thousands of California ovarian cancer patients, UC Davis researchers have determined that almost one-third survived at least 10 years after diagnosis.